The authors initially employed the CSF1R inhibitor PLX5622 or the genetic tool Clec4fcreCsf1rf/f/Spi1f/f to deplete KCs in tumor‐bearing mice, and the results demonstrated a significant increase in liver metastatic tumor cells in KC‐deficient mice. This evidence concerns the gene TBCE and neoplasm.